bicalutamide and nu2058

bicalutamide has been researched along with nu2058 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Curtin, NJ; Rigas, AC; Robson, CN	1

Other Studies

1 other study(ies) available for bicalutamide and nu2058

Article	Year
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer. Oncogene, 2007, Dec-06, Volume: 26, Issue:55 Topics: Androgens; Anilides; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Guanine; Humans; Male; Nitriles; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Retinoblastoma Protein; Tosyl Compounds	2007

Article

Year

Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.

Oncogene, 2007, Dec-06, Volume: 26, Issue:55

Topics: Androgens; Anilides; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Guanine; Humans; Male; Nitriles; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Retinoblastoma Protein; Tosyl Compounds

2007